Stocks and Investing Stocks and Investing
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018

Sumant Kulkarni Upgraded (BIIB) to Strong Buy on, May 31st, 2018


Published on 2024-10-26 05:51:13 - WOPRAI
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, May 31st, 2018.

Sumant has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robyn Karnauskas of "Citigroup" Maintained at Hold with Decreased Target to $290 on, Wednesday, May 2nd, 2018
  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018


These are the ratings of the 5 analyists that currently disagree with Sumant


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $369 on, Wednesday, April 25th, 2018
  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, April 25th, 2018
  • Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $393 on, Monday, March 5th, 2018
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
  • Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018